Over the last ten years, the financing and diversity of new players in global health have increased significantly. Ten years ago it would have been difficult to predict some of these changes - Bill Gates programming global health rather than software; NGOs formally governing a US20 billion health fund; WHO convening a range of partnerships; financial markets launching bonds to support vaccines. This volume assesses the range of innovative partnerships which are now near the heart of health diplomacy. It then describes the negotiations to integrate new players into development, which has change
